Advertisement
UK markets close in 8 hours 10 minutes
  • FTSE 100

    7,951.45
    +19.47 (+0.25%)
     
  • FTSE 250

    19,831.40
    +20.74 (+0.10%)
     
  • AIM

    743.27
    +1.16 (+0.16%)
     
  • GBP/EUR

    1.1682
    +0.0013 (+0.11%)
     
  • GBP/USD

    1.2608
    -0.0030 (-0.24%)
     
  • Bitcoin GBP

    55,853.28
    +407.88 (+0.74%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • S&P 500

    5,248.49
    +44.91 (+0.86%)
     
  • DOW

    39,760.08
    +477.75 (+1.22%)
     
  • CRUDE OIL

    81.77
    +0.42 (+0.52%)
     
  • GOLD FUTURES

    2,212.70
    0.00 (0.00%)
     
  • NIKKEI 225

    40,168.07
    -594.66 (-1.46%)
     
  • HANG SENG

    16,558.25
    +165.41 (+1.01%)
     
  • DAX

    18,483.20
    +6.11 (+0.03%)
     
  • CAC 40

    8,225.07
    +20.26 (+0.25%)
     

Medica Group Full Year 2022 Earnings: Revenues Beat Expectations, EPS Lags

Medica Group (LON:MGP) Full Year 2022 Results

Key Financial Results

  • Revenue: UK£77.0m (up 24% from FY 2021).

  • Net income: UK£7.20m (up 32% from FY 2021).

  • Profit margin: 9.4% (up from 8.8% in FY 2021). The increase in margin was driven by higher revenue.

  • EPS: UK£0.059 (up from UK£0.046 in FY 2021).

earnings-and-revenue-growth
earnings-and-revenue-growth

All figures shown in the chart above are for the trailing 12 month (TTM) period

Medica Group Revenues Beat Expectations, EPS Falls Short

Revenue exceeded analyst estimates by 1.3%. Earnings per share (EPS) missed analyst estimates by 19%.

Looking ahead, revenue is forecast to grow 7.7% p.a. on average during the next 3 years, compared to a 4.8% growth forecast for the Healthcare industry in the United Kingdom.

ADVERTISEMENT

Performance of the British Healthcare industry.

The company's shares are up 5.0% from a week ago.

Balance Sheet Analysis

While it's very important to consider the profit and loss statement, you can also learn a lot about a company by looking at its balance sheet. See our latest analysis on Medica Group's balance sheet health.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Join A Paid User Research Session
You’ll receive a US$30 Amazon Gift card for 1 hour of your time while helping us build better investing tools for the individual investors like yourself. Sign up here